Adam Logal
Fortune : 900 327 $ au 31/05/2026
Fortune : 900 327 $ au 31/05/2026
Adam E.
Logal is currently Director at Bio-Reference Laboratories, Inc. since 2015, Director at OPKO Biologics Ltd. since 2014, Director at Non-Invasive Monitoring Systems, Inc. starting 2025, and CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. since 2021.
Former positions include Chairman at Xenetic Biosciences, Inc. from 2017 to 2024, Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc. in 2007, Independent Director at VBI Vaccines, Inc. from 2014 to 2018, Director at SciVac Therapeutics, Inc., Chief Financial & Accounting Officer at Nabi Biopharmaceuticals from 2002 to 2007, and President at GeneDx LLC from 2020 to 2021.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPKO HEALTH, INC. 0,08% | 27/05/2025 | 616 662 ( 0,08% ) | 900 327 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| OPKO HEALTH, INC. | Directeur Financier/CFO | 31/03/2014 |
| BIO-REFERENCE LABORATORIES INC | Directeur/Membre du Conseil | 20/08/2015 |
| NON-INVASIVE MONITORING SYSTEMS, INC. | Directeur/Membre du Conseil | 03/09/2025 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Directeur/Membre du Conseil | 01/04/2014 |
| Sociétés | Poste | Fin |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Président | 11/12/2024 |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | President | 01/06/2021 |
| VBI VACCINES INC. | Directeur/Membre du Conseil | 01/10/2018 |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Financier/CFO | 13/06/2007 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Directeur Financier/CFO | 01/01/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Commercial Services |
Non-Invasive Monitoring Systems, Inc.
Non-Invasive Monitoring Systems, Inc. Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
eXegenics, Inc.
eXegenics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. BiotechnologyHealth Technology Operates as a drug development company that develops bio-better long-acting therapeutic proteins | Health Technology |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
SciVac Therapeutics, Inc.
SciVac Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
VBI Vaccines, Inc.
VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Provides genomic testing services | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national